Literature DB >> 21063676

Severe hyperkalemia induced by a short interruption of barbiturate coma.

Eleni E Magira, Konstantinos Sakellaridis, Paraskeui Tselioti, Barbara Grammatikopoulou, Athanasios Prekates.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21063676     DOI： 10.1007/s00134-010-2068-1

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN： 0342-4642            Impact factor:   17.440


× No keyword cloud information.
  5 in total

1.  Complications and side effects during thiopentone therapy in patients with severe head injuries.

Authors:  W Schalén; K Messeter; C H Nordström
Journal:  Acta Anaesthesiol Scand       Date:  1992-05       Impact factor: 2.105

2.  Does barbiturate therapy cause severe hypokalemia?

Authors:  K Irita; T Kawasaki; T Uenotsuchi; Y Sakaguchi; S Takahashi
Journal:  Anesth Analg       Date:  1998-01       Impact factor: 5.108

3.  Hypokalaemia with severe rebound hyperkalaemia after therapeutic barbiturate coma.

Authors:  Michael J E Neil; Megan C Dale
Journal:  Anesth Analg       Date:  2009-06       Impact factor: 5.108

4.  Life-threatening hyperkalaemia following therapeutic barbiturate coma.

Authors:  Christopher J S Cairns; Benjamin Thomas; Stephen Fletcher; Michael J A Parr; Simon R Finfer
Journal:  Intensive Care Med       Date:  2002-07-18       Impact factor: 17.440

5.  Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.

Authors:  R Z Kozlowski; M L Ashford
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739
  5 in total
  1 in total

1.  Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Daniel De Backer; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Jordi Mancebo; Salvatore M Maggiore; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-01-04       Impact factor: 17.440
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.